Dermatology · Indianapolis, IN
NPI
1023011244
Since 2005
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
7910 N Shadeland Ave
Indianapolis, IN, 46250
Phone (317) 516-5000
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.1M
15,785 services
Medicare patients, 2024
2,474
Average age 75
Drug cost, 2024
$4.4M
2,883 prescriptions
Company payments, 2025
$110K
From 27 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Scott A Fretzin was code J3245 (injection, tildrakizumab, 1 mg), 6,700 times for 27 patients. In total Scott A Fretzin billed 15,785 services in 92 codes, and Medicare paid $1.1M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-04-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3245 Injection, tildrakizumab, 1 mg | Office | 6,700 | 27 | $107.15 | $718K |
| 99213 Office E&M - Established | Office | 1,945 | 1,594 | $55.12 | $107K |
| 17003 Destruction Skin Lesion | Office | 1,887 | 559 | $4.49 | $8,481 |
| 17000 Destruction Skin Lesion | Office | 1,182 | 955 | $35.75 | $42K |
| 99214 Office E&M - Established | Office | 733 | 617 | $76.27 | $56K |
| 17110 Destruction Skin Lesion | Office | 478 | 440 | $71.31 | $34K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 360 | 82 | $0.74 | $268 |
| 11102 Skin Biopsy | Office | 356 | 331 | $59.80 | $21K |
| 88305 Surgical Pathology Examination | Office | 303 | 206 | $51.06 | $15K |
| 99203 Office E&M - New | Office | 220 | 220 | $64.73 | $14K |
| 96910 Skin | Office | 206 | 27 | $83.70 | $17K |
| 96372 Injection Administration | Office | 116 | 71 | $9.85 | $1,143 |
| 11103 Skin Biopsy | Office | 69 | 50 | $35.15 | $2,425 |
| 96920 Skin | Office | 64 | 12 | $113.54 | $7,267 |
| 99204 Office E&M - New | Office | 58 | 58 | $84.47 | $4,899 |
By year: 2022 $594K for 10,512 services; 2023 $769K for 12,363 services; 2024 $1.1M for 15,785 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88305 Surgical Pathology Examination | 303 | 206 | $51.06 | $15K |
| 88304 Surgical Pathology Examination | 12 | 11 | $26.53 | $318 |
Medicare prescription drug claims, 2024
In 2024, the drug Scott A Fretzin prescribed most often to Medicare patients was Triamcinolone Acetonide, with 311 prescriptions and refills. In total Scott A Fretzin wrote 2,883 Medicare prescriptions that cost $4.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Triamcinolone Acetonide Generic | 311 | 385 | 193 | $3,855 |
| Fluocinonide Generic | 230 | 269 | 147 | $9,406 |
| Clobetasol Propionate Generic | 206 | 252 | 98 | $9,012 |
| Fluconazole Generic | 157 | 247 | 48 | $1,605 |
| Ketoconazole Generic | 153 | 181 | 61 | $2,828 |
| Doxycycline Hyclate Generic | 140 | 160 | 69 | $2,281 |
| Minoxidil Generic | 103 | 226 | 32 | $1,091 |
| Valacyclovir Valacyclovir Hcl | 94 | 122 | 43 | $2,042 |
| Ciclopirox Generic | 84 | 101 | 45 | $3,360 |
| Fluorouracil Generic | 73 | 81 | 61 | $5,658 |
| Clindamycin Phosphate Generic | 71 | 85 | 32 | $3,115 |
| Betamethasone Dipropionate Generic | 66 | 77 | 31 | $2,276 |
| Doxepin Hcl Generic | 65 | 89 | 17 | $2,028 |
| Hydrocortisone Generic | 64 | 72 | 43 | $422 |
| Humira(Cf) Pen Adalimumab | 60 | 60 | Under 11 | $649K |
Brand drugs: 557 claims; generic drugs: 2,326 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Scott A Fretzin $110K ($108K in general payments such as food, travel and fees and $1,638 for research) from 27 companies. The largest payer was Janssen Biotech, Inc. with $25K.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 24 | $25K |
| Incyte Corporation INCY | 19 | $18K |
| Abbvie Inc. ABBV | 35 | $17K |
| Amgen Inc. AMGN | 29 | $14K |
| Lilly USA, LLC LLY | 15 | $11K |
| UCB, Inc. UCB.BR | 20 | $9,145 |
| E.R. Squibb & Sons, L.L.C. BMY | 8 | $7,899 |
| Organon LLC OGN | 6 | $3,422 |
| Regeneron Pharmaceuticals, Inc. REGN | 8 | $1,638 |
| Galderma Laboratories, L.P. GALD.SW | 22 | $640 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.